World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ANZCTR
Last refreshed on: 13 January 2020
Main ID:  ACTRN12614001291673
Date of registration: 10/12/2014
Prospective Registration: Yes
Primary sponsor: World Vision Kenya
Public title: Low Intensity Intervention to Reduce Depression and Anxiety in Women Exposed to Gender-Based Violence
Scientific title: Exploratory Randomised Controlled Trial of Problem Management Plus versus Enhanced Treatment as Usual to Reduce Depression and Anxiety in Women Exposed to Gender-Based Violence
Date of first enrolment: 15/04/2015
Target sample size: 346
Recruitment status: Completed
URL:  https://anzctr.org.au/ACTRN12614001291673.aspx
Study type:  Interventional
Study design:  Purpose: Treatment; Allocation: Randomised controlled trial; Masking: Blinded (masking used);Assignment: Parallel;Type of endpoint: Efficacy;  
Phase:  Not Applicable
Countries of recruitment
Kenya
Contacts
Name: Prof Richard Bryant   
Address:  School of Psychology University of New South Wales Sydney NSW 2052 Australia
Telephone: 61293853640
Email: r.bryant@unsw.edu.au
Affiliation: 
Name: Ms Dorothy Anjuri   
Address:  World Vision Kenya-Karen Office P.O. Box 50816-00200 Nairobi Kenya
Telephone: 254 20883652
Email: dorothy_anjuri@wvi.org
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: Women exposed to gender-based violence and indicate significant distress as reflected in scores on GHQ > 2 and impaired functioning reflected in scores on WHODAS > 16
Exclusion criteria: (a) Imminent suicidal intent, (b) severe mental disorder, (c) severe cognitive impairment, (d) acute protection risks, (e) exposure to trauma in last month, (f) male gender, (g) acute protection risks

Age minimum: 18 Years
Age maximum: No limit
Gender: Females
Health Condition(s) or Problem(s) studied
Mental Health - Depression
Mental Health - Anxiety
Posttraumatic stress disorder;Depression;Anxiety;
Posttraumatic stress disorder
Depression
Anxiety
Intervention(s)
There are two arms to this trial. Arm 1: Problem Management Plus. Arm 2: Enhanced Treatment as Usual. Therapy is administered once-weekly over 5 weeks on an individual 90 minute basis. Problem Management Plus includes skills in identifying emotional and practical problems that can be managed and strategies to reduce and cope with these problems. The duration of the study for any participant will conclude after immediate post-trial follow-up assessment, resulting in participation duration of 1.5 months. Therapy is provided by local health workers.
Primary Outcome(s)
Anxiety and depression are a composite outcome that are measured by mean score on the General Health Questionnaire[Pretreatment (week 1), posttreatment (week 7)]
Secondary Outcome(s)
Mean scores on the World Health Organisation Disability Assessment Schedule 2.0[Pretreatment (week 1), posttreatment (week 7)]
Health service use as measured by reported access of Nairobi health services [Pretreatment (week 1), follow up (week 13) ]
Stressful life events as measured by the Life Events Checklist [Pretreatment (week 1), follow up (week 13) ]
Mean scores on the Posttraumatic Stress Disorder Checklist[Pretreatment (week 1), posttreatment (week 2)]
Personalised outcomes as measured by the Psychological Outcomes Profile (PSYCHLOPS) scale [Pretreatment (week 1), posttreatment (week 7), follow up (week 13) ]
Secondary ID(s)
Nil
Source(s) of Monetary Support
Grand Challenges Canada
Secondary Sponsor(s)
World Health Organisation
Ethics review
Status: Approved
Approval date:
Contact:
World Health Organisation Ethics Review Committee
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history